Year: 2022
Type: article
Abstract: Ten years after the launch of the Future Investment Program (Programme d'Investissement d'Avenir, PIA) and the implementation of these tools, one of Giens' roundtable workshop wanted to further explore the impact of PIA on health research and innovation with the aim of preparing action reports (bibliometrics, valuation, reputation) based on 2019 findings and the history of PIA deployment in relation to the healthcare sector; to analyze the development of the industrial sector vis-a-vis the PIA actions and to examine how the specific actions and the healthcare sector in general were able to duly articulate themselves, or, take form, given existing structures or organizations and contribute to site policies through Idex/Isite. Five success keys have been identified, which should serve as a strategic compass for future action plans to develop health innovation: Full trust governance between the project manager and the institution, driven by project objectives; An increased role of universities in the steering of PIA objects, joining together in a federation, in a site policy with the Hospital University Centres and Public Scientific and Technological Establishments; A simplification of public/private partnership schemes, in the nature of the Assessment and Action Plans, and in the responsiveness of the institutions; help with the development of local ecosystems, the fostering and support of young researchers; early cross-fertilization between the academic and industrial worlds.
Source: Therapies
Authors: Régis Bordet, Jean-Christophe Dantonel, Eric Vacaresse, Claire Le Jeunne, Nora Benhabiles, Alain Beretz, Christian Boitard, Stéphanie Debette, Gilles Duluc, Philippe Froguel, Bénédicte Garbil, Stanislas Lyonnet, Abderrahim Mahfoudi, Pierre Marquet, Franck Mouthon, Olivier Rascol, Vincent Richard, Emmanuelle Simon, Nathalie Varoqueaux, Hervé Watier, Marie Zins
Institutions: Inserm, Université de Lille, Sanofi (France), Université Paris Cité, Assistance Publique – Hôpitaux de Paris, Commissariat à l'Énergie Atomique et aux Énergies Alternatives, Université Paris-Saclay, CEA Paris-Saclay - Etablissement de Saclay, Direction de la Recherche Fondamentale, CEA Paris-Saclay, Université de Strasbourg, Université de Bordeaux, Centre Hospitalier Universitaire de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux Population Health, Centre National de la Recherche Scientifique, Institut des Maladies Génétiques Imagine, Pierre Fabre (France), Pharmacologie & Transplantation, Université de Limoges, Paris Biotech Santé, Université de Rouen Normandie, Agence Nationale de la Recherche, Centre Hospitalier Universitaire de Tours, Hôpital Paul-Brousse, Cohortes épidémiologiques en population
Language: English
Subfield: Management of Technology and Innovation
Domain: Social Sciences
Open Access status: hybrid
Estimated APC paid: $2,160
OpenAlex ID: W4206270676